Patents/Assignees

EXELA PHARMA SCIENCES, LLC

12 patents in portfolio

US12569514utility2026
Stable, Highly Pure L-cysteine Compositions for Injection and Methods of Use
0 cites
US12569513utility2026
Stable, Highly Pure L-cysteine Compositions for Injection and Methods of Use
0 cites
US12186338utility2025
Stable, Highly Pure L-cysteine Compositions for Injection and Methods of Use
0 cites
US12171781utility2024
Stable, Highly Pure L-cysteine Compositions for Injection and Methods of Use
0 cites
US11969439utility2024
Stable, Highly Pure L-cysteine Compositions for Injection and Methods of Use
0 cites
US11826383utility2023
Stable, Highly Pure L-cysteine Compositions for Injection and Methods of Use
0 cites
US11723978utility2023
Ganciclovir Compositions and Related Methods
0 cites
US11684636utility2023
Stable, Highly Pure L-cysteine Compositions for Injection and Methods of Use
0 cites
US11679125utility2023
Stable, Highly Pure L-cysteine Compositions for Injection and Methods of Use
0 cites
US11672824utility2023
Stable, Highly Pure L-cysteine Compositions for Injection and Methods of Use
0 cites
US11648262utility2023
Stable, Highly Pure L-cysteine Compositions for Injection and Methods of Use
0 cites
US11642370utility2023
Stable, Highly Pure L-cysteine Compositions for Injection and Methods of Use
0 cites